On May 20, 2022, Artelo Biosciences, Inc. closed the transaction. The company has received $96,972 in the transaction. The transaction included participation from a single investor.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.511 USD | -0.91% | +14.47% | +7.94% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.94% | 4.92M | |
+10.17% | 114B | |
+12.52% | 107B | |
-3.90% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-7.11% | 17.51B | |
-39.36% | 17.17B | |
+6.25% | 14.14B | |
+32.96% | 12.2B |
- Stock Market
- Equities
- ARTL Stock
- News Artelo Biosciences, Inc.
- Artelo Biosciences, Inc. announced that it has received $0.9672 million in funding